Healthcare and Life Sciences Deal Activity Will Be Robust in 2021: KPMG Survey
The FINANCIAL-- Volume of deals rises 15% aided by late 2020 surge, despite pandemic -- Growing valuations seen in biopharma, ...
ADVERTISEMENT
Tag: despite pandemic — Growing valuations seen in biopharma
ADVERTISEMENT
Popular Last 24h
-
Anurag Bajpayee’s Gradiant : The Water Tech Firm Rides Industrial Demand Toward Global Expansion
-
H.I.G. Capital Ramps Up Acquisition Strategy with Tech and Events Industry Plays
-
The Security Service of Ukraine lost the appeal in court to Alona Shevtsova, Ibox Bank
-
Ampersand wins £22m five-year contract at London Zoo
-
Future-Proofing Your Workplace: Adapting to the Needs of a Modern Workforce
-
Who Is the Owner of QI Company? A Look at the QI Group’s Leadership Shaping Its Future
-
Childhood tuberculosis cases rise by 10%: a disturbing wake-up call for Europe
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
